» Authors » Raphael Marechal

Raphael Marechal

Explore the profile of Raphael Marechal including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 38
Citations 1238
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Laurent A, Marechal R, Farinella E, Bouazza F, Charaf Y, Gay F, et al.
Thorac Cancer . 2022 Aug; 13(19):2699-2710. PMID: 36000335
Background: This analysis evaluated the morbimortality and the potential benefit of esophagectomy for cancer in elderly patients. Methods: Patients who underwent esophagectomy for EC were divided into elderly (≥70 years)...
2.
Demetter P, Marechal R, Puleo F, Delhaye M, Debroux S, Charara F, et al.
Front Oncol . 2021 Mar; 11:630086. PMID: 33747949
Undifferentiated carcinoma of the pancreas is an aggressive but rare tumor for which several other terms have been used to describe its histological appearance. In addition, as osteoclast-like giant cells...
3.
Gidron Y, De Couck M, Reynders T, Marechal R, Engelborghs S, Dhooghe A
J Clin Med . 2019 Dec; 9(1). PMID: 31877665
'Mind-body' debates assume that better brain-body associations are healthy. This study examined whether degree of associations between a neurophysiological vagal nerve index and peripheral disease biomarkers predict prognosis in pancreatic...
4.
Raffenne J, Nicolle R, Puleo F, Le Corre D, Boyez C, Marechal R, et al.
Cancers (Basel) . 2019 Nov; 11(11). PMID: 31752123
Gemcitabine is still one of the standard chemotherapy regimens for pancreatic ductal adenocarcinoma (PDAC). Gemcitabine uptake into tumor cells is mainly through the human equilibrative nucleoside transport 1 (hENT1). It...
5.
Puleo F, Nicolle R, Blum Y, Cros J, Marisa L, Demetter P, et al.
Gastroenterology . 2018 Aug; 155(6):1999-2013.e3. PMID: 30165049
Background & Aims: Genomic studies have revealed subtypes of pancreatic ductal adenocarcinoma (PDA) based on their molecular features, but different studies have reported different classification systems. It is a challenge...
6.
Antonietta Bali M, Pullini S, Metens T, Absil J, Chao S, Marechal R, et al.
Eur J Radiol . 2018 Jun; 104:49-57. PMID: 29857866
Purpose: To prospectively assess chemotherapy-induced changes in pancreatic ductal adenocarcinoma (PDA) with diffusion-weighted (DW)-MR quantitative metrics, including apparent diffusion coefficient (ADC) and histogram-derived parameters, compared with RECIST 1.1. Methods: 24...
7.
Marechal R, Puleo F, Demols A, Verset G, Van Laethem J
Per Med . 2018 May; 12(5):515-523. PMID: 29749894
Pancreatic ductal adenocarcinoma carries a dismal prognosis. Both chemotherapy and targeted therapies have been disappointing when administered to unselected populations. Recently, progress has been made in our understanding of the...
8.
Vandeputte C, Kehagias P, El Housni H, Ameye L, Laes J, Desmedt C, et al.
Oncotarget . 2018 May; 9(25):17756-17769. PMID: 29707145
Predictive biomarkers are eagerly awaited in advanced colorectal cancer (aCRC). Targeted sequencing performed on tumor and baseline plasma samples in 20 patients with aCRC treated with regorafenib identified 89 tumor-specific...
9.
Lupinacci R, Goloudina A, Buhard O, Bachet J, Marechal R, Demetter P, et al.
Gastroenterology . 2017 Nov; 154(4):1061-1065. PMID: 29158190
Microsatellite instability (MSI) caused by mismatch repair deficiency (dMMR) is detected in a small proportion of pancreatic ductal adenocarcinomas (PDACs). dMMR and MSI have been associated with responses of metastatic...
10.
Bunel V, Tournay Y, Baudoux T, De Prez E, Marchand M, Mekinda Z, et al.
Clin Kidney J . 2017 Oct; 10(5):639-647. PMID: 28979774
Background: Renal toxicity induced by cisplatin (CisPt) is a clinical issue in patients with or without chronic kidney disease (CKD). Proximal tubular injury can result in acute kidney injury (AKI),...